Kitazato (368A.T) Stock Price

Kitazato Price

CLOSED
1,293.00
​
Market closed

Revenue has compounded at 5.0% per year over the past 2 years to 10.30 B JPY. Earnings per share have grown at 6.0% per year over the last 2 years. Kitazato's net margin stands at 36.8%, broadly stable from 36.1% several years earlier.

Kitazato stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato business model & stock analysis

Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies.

Frequently asked questions about Kitazato

Converted at the current exchange rate, the Kitazato share trades at 7.29 EUR (1,293.00 JPY).

The expected revenue of Kitazato is 11.01 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Kitazato is 3.69 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Kitazato is currently 14.02. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Kitazato stock.

The price-to-sales ratio (P/S) of Kitazato is currently 4.70. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Kitazato stock.

The Eulerpool Quality Score for Kitazato is 5/10.

The ISIN of Kitazato is JP3237550003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Kitazato is 368A.T. The ticker symbol is used to trade Kitazato shares on the stock exchange.

Fair ValueTerminal
1,176.63 JPY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
JPY
Initial public offering
Jun 25, 2025
ISIN
JP3237550003
Cusip
J34385104
Market capitalization
51.72 B JPYLarge Cap
52-Week Range
PEG
3.47
P/E ratio
P/Ee 2026
14.02
P/Ee 2027
13.36
P/Ee 2028
12.49
P/S
P/Se
4.70
EV/EBIT
6.98
P/B Ratio
2.83
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
20.62 %
Last updated Nov 11, 2026, 8:47 PM

Kitazato Peer Group

All fundamentals and in-depth analysis of Kitazato

Our stock analysis for Kitazato stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kitazato. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.